Sal Trading, LLC Novartis Ag Transaction History

Sal Trading, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$92.27 - $101.54 $313,718 - $345,236	-3,400 Reduced 32.69%	7,000 $706,000
Q3 2023 Nov 14, 2023	BUY	$94.73 - $105.13 $985,192 - $1.09 Million	10,400 New	10,400 $1.06 Million
Q2 2022 Aug 15, 2022	SELL	$80.52 - $93.75 $12.5 Million - $14.6 Million	-155,783 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$80.11 - $90.62 $12.5 Million - $14.1 Million	155,783 New	155,783 $13.7 Million

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Sal Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Sal Trading, LLC with notifications on news.